Clincosm LogoSign in Get a demo

Gastrointestinal Stromal Tumors

Showing NaN - NaN of 11
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Gastrointestinal Stromal Tumors Trial in Worldwide (DCC-2618, Placebo Oral Tablet)

Completed
Has Results
  • Gastrointestinal Stromal Tumors
  • Scottsdale, Arizona
  • +34 more
Nov 17, 2022

Gastrointestinal Stromal Tumors, Sdh, GIST Trial in United States (Temozolomide)

Recruiting
  • Gastrointestinal Stromal Tumors
  • +3 more
  • La Jolla, California
  • +4 more
Aug 17, 2021

Gastrointestinal Stromal Tumors Trial in Worldwide (RAD001, Imatinib 600mg/day (Glevec is the brand name for imatinib), Imatinib

Completed
Has Results
  • Gastrointestinal Stromal Tumors
  • Boston, Massachusetts
  • +15 more
Jun 3, 2021

Gastrointestinal Stromal Tumors, Advanced Systemic Mastocytosis, Advanced Cancers Trial in Worldwide (DCC-2618)

Active, not recruiting
  • Gastrointestinal Stromal Tumors
  • +2 more
  • Scottsdale, Arizona
  • +25 more
Apr 16, 2021

Gastrointestinal Stromal Tumors Trial in Worldwide (Regorafenib (Stivarga, BAY73-4506), Placebo, Best supportive care)

Completed
Has Results
  • Gastrointestinal Stromal Tumors
  • Regorafenib (Stivarga, BAY73-4506)
  • +2 more
  • Scottsdale, Arizona
  • +56 more
Jan 27, 2021

Gastrointestinal Stromal Tumors Trial in Worldwide (DCC-2618, Sunitinib)

Unknown status
  • Gastrointestinal Stromal Tumors
  • Scottsdale, Arizona
  • +120 more
Jan 4, 2021

Gastrointestinal Stromal Tumors Trial in Worldwide (AMN107, STI571)

Completed
  • Gastrointestinal Stromal Tumors
  • AMN107, STI571
  • Boston, Massachusetts
  • +4 more
Dec 6, 2020

Gastrointestinal Stromal Tumors Trial in United States (Imatinib mesylate)

Terminated
Has Results
  • Gastrointestinal Stromal Tumors
  • Imatinib mesylate
  • Los Angeles, California
  • +12 more
Aug 22, 2013

Gastrointestinal Stromal Tumors Trial in France, Italy, United States (Nilotinib, Imatinib)

Completed
  • Gastrointestinal Stromal Tumors
  • Nilotinib, Imatinib
  • Boston, Massachusetts
  • +3 more
May 9, 2013

Gastrointestinal Stromal Tumors Trial in Philadelphia (Nilotinib)

Terminated
Has Results
  • Gastrointestinal Stromal Tumors
  • Philadelphia, Pennsylvania
    Fox Chase Cancer Center
Apr 15, 2013

Gastrointestinal Stromal Tumors Trial in Worldwide (Nilotinib, Best Supportive Care (BSC) +/- imatinib or sunitinib)

Completed
Has Results
  • Gastrointestinal Stromal Tumors
  • Nilotinib
  • Best Supportive Care (BSC) +/- imatinib or sunitinib
  • Los Angeles, California
  • +34 more
Jun 5, 2012